|
1
|
Li AC and Glass CK: The macrophage foam
cell as a target for therapeutic intervention. Nat Med.
8:1235–1242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Palinski W, Ord VA, Plump AS, Breslow JL,
Steinberg D and Witztum JL: ApoE-deficient mice are a model of
lipoprotein oxidation in atherogenesis. Demonstration of
oxidation-specific epitopes in lesions and high titers of
autoantibodies to malondialdehyde-lysine in serum. Arterioscler
Thromb. 14:605–616. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–26. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mitka M: Cholesterol drug lowers LDL-C
levels but again fails to show clinical benefit. JAMA. 303:211–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herrmann J, Lerman LO, Rodriguez-Porcel M,
Holmes DR Jr, Richardson DM, Ritman EL and Lerman A: Coronary vasa
vasorum neovascularization precedes epicardial endothelial
dysfunction in experimental hypercholesterolemia. Cardiovasc Res.
51:762–766. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Staub D, Patel MB, Tibrewala A, Ludden D,
Johnson M, Espinosa P, Coll B, Jaeger KA and Feinstein SB: Vasa
vasorum and plaque neovascularization on contrast-enhanced carotid
ultrasound imaging correlates with cardiovascular disease and past
cardiovascular events. Stroke. 41:41–47. 2010. View Article : Google Scholar
|
|
7
|
Langheinrich AC, Michniewicz A, Sedding
DG, Walker G, Beighley PE, Rau WS, Bohle RM and Ritman EL:
Correlation of vasa vasorum neovascularization and plaque
progression in aortas of apolipoprotein E(−/−)/low-density
lipoprotein(−/−) double knockout mice. Arterioscler Thromb Vasc
Biol. 26:347–352. 2006. View Article : Google Scholar
|
|
8
|
Tanaka K, Nagata D, Hirata Y, Tabata Y,
Nagai R and Sata M: Augmented angiogenesis in adventitia promotes
growth of atherosclerotic plaque in apolipoprotein E-deficient
mice. Atherosclerosis. 215:366–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gössl M, Herrmann J, Tang H, Versari D,
Galili O, Mannheim D, Rajkumar SV, Lerman LO and Lerman A:
Prevention of vasa vasorum neovascularization attenuates early
neointima formation in experimental hypercholesterolemia. Basic Res
Cardiol. 104:695–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilson SH, Herrmann J, Lerman LO, Holmes
DR Jr, Napoli C, Ritman EL and Lerman A: Simvastatin preserves the
structure of coronary adventitial vasa vasorum in experimental
hypercholesterolemia independent of lipid lowering. Circulation.
105:415–418. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moulton KS, Vakili K, Zurakowski D,
Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K
and Folkman J: Inhibition of plaque neovascularization reduces
macrophage accumulation and progression of advanced
atherosclerosis. Proc Natl Acad Sci USA. 100:4736–4741. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moulton KS, Heller E, Konerding MA, Flynn
E, Palinski W and Folkman J: Angiogenesis inhibitors endostatin or
TNP-470 reduce intimal neovascularization and plaque growth in
apolipoprotein E-deficient mice. Circulation. 99:1726–1732. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen WQ, Zhong L, Zhang L, Ji XP, Zhao YX,
Zhang C, Jiang H, Wu YL and Zhang Y: Chinese medicine tongxinluo
significantly lowers serum lipid levels and stabilizes vulnerable
plaques in a rabbit model. J Ethnopharmacol. 124:103–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Liu Y, Lu XT, Wu YL, Zhang C, Ji
XP, Wang R, Liu CX, Feng JB, Jiang H, et al: Traditional Chinese
medication Tongxinluo dose-dependently enhances stability of
vulnerable plaques: A comparison with a high-dose simvastatin
therapy. Am J Physiol Heart Circ Physiol. 297:H2004–H2014. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weidner N, Carroll P, Flax J, Blumenfeld W
and Folkman J: Tumor angiogenesis correlates with metastasis in
invasive prostate carcinoma. Am J Pathol. 143:401–409.
1993.PubMed/NCBI
|
|
16
|
Purushothaman KR, Sanz J, Zias E, Fuster V
and Moreno PR: Atherosclerosis neovascularization and imaging. Curr
Mol Med. 6:549–56. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roy H, Bhardwaj S, Babu M, Kokina I,
Uotila S, Ahtialansaari T, Laitinen T, Hakumaki J, Laakso M, Herzig
KH and Ylä-Herttuala S: VEGF-A, VEGF-D, VEGF receptor-1, VEGF
receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of
diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J.
20:2159–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moulton KS: Angiogenesis in
atherosclerosis: gathering evidence beyond speculation. Curr Opin
Lipidol. 17:548–55. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamura R, Sene A, Santeford A, Gdoura A,
Kubota S, Zapata N and Apte RS: IL10-driven STAT3 signalling in
senescent macrophages promotes pathological eye angiogenesis. Nat
Commun. 6:78472015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szöcs K, Lassègue B, Sorescu D, Hilenski
LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD and
Griendling KK: Upregulation of Nox-based NAD(P)H oxidases in
restenosis after carotid injury. Arterioscler Thromb Vasc Biol.
22:21–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moreno PR, Purushothaman KR, Fuster V,
Echeverri D, Truszczynska H, Sharma SK, Badimon JJ and O'Connor WN:
Plaque neovascularization is increased in ruptured atherosclerotic
lesions of human aorta: Implications for plaque vulnerability.
Circulation. 110:2032–2038. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weis M, Heeschen C, Glassford AJ and Cooke
JP: Statins have biphasic effects on angiogenesis. Circulation.
105:739–745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian J, Hu S, Jia H, Hou J, Zhang S, Yu B
and Jang IK: Correlation of vasa vasorum and plaque progression and
response to atorvastatin therapy an a rabbit model of
atherosclerosis: In vivo intravascular ultrasound and
contrast-enhanced ultrasound imaging study. J Am Coll Card.
59:E10722012. View Article : Google Scholar
|
|
24
|
Bot I, Jukema JW, Lankhuizen IM, van
Berkel TJ and Biessen EA: Atorvastatin inhibits plaque development
and adventitial neovascularization in ApoE deficient mice
independent of plasma cholesterol levels. Atherosclerosis.
214:295–300. 2011. View Article : Google Scholar
|
|
25
|
Fleiner M, Kummer M, Mirlacher M, Sauter
G, Cathomas G, Krapf R and Biedermann BC: Arterial
neovascularization and inflammation in vulnerable patients: Early
and late signs of symptomatic atherosclerosis. Circulation.
110:2843–2850. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moreno PR, Purushothaman KR, Sirol M, Levy
AP and Fuster V: Neovascularization in human atherosclerosis.
Circulation. 113:2245–2252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rademakers T, Douma K, Hackeng TM, Post
MJ, Sluimer JC, Daemen MJ, Biessen EA, Heeneman S and van Zandvoort
MA: Plaque-associated vasa vasorum in aged apolipoprotein
E-deficient mice exhibit proatherogenic functional features in
vivo. Arterioscler Thromb Vasc Biol. 33:249–256. 2013. View Article : Google Scholar
|
|
28
|
Kim YW and Byzova TV: Oxidative stress in
angiogenesis and vascular disease. Blood. 123:625–631. 2014.
View Article : Google Scholar :
|
|
29
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen J, Liu B, Yuan J, Yang J, Zhang J, An
Y, Tie L, Pan Y and Li X: Atorvastatin reduces vascular endothelial
growth factor (VEGF) expression in human non-small cell lung
carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS)
production. Mol Oncol. 6:62–72. 2012. View Article : Google Scholar
|
|
31
|
Vepa S, Scribner WM, Parinandi NL, English
D, Garcia JG and Natarajan V: Hydrogen peroxide stimulates tyrosine
phosphorylation of focal adhesion kinase in vascular endothelial
cells. Am J Physiol. 277:L150–L158. 1999.PubMed/NCBI
|
|
32
|
Shono T, Ono M, Izumi H, Jimi SI,
Matsushima K, Okamoto T, Kohno K and Kuwano M: Involvement of the
transcription factor NF-kappaB in tubular morphogenesis of human
microvascular endothelial cells by oxidative stress. Mol Cell Biol.
16:4231–4239. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Giacca M and Zacchigna S: VEGF gene
therapy: Therapeutic angiogenesis in the clinic and beyond. Gene
Ther. 19:622–629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Griendling KK, Sorescu D and Ushio-Fukai
M: NAD(P)H oxidase: Role in cardiovascular biology and disease.
Circ Res. 86:494–501. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vignais PV: The superoxide-generating
NADPH oxidase: Structural aspects and activation mechanism. Cell
Mol Life Sci. 59:1428–1459. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Konior A, Schramm A, Czesnikiewicz-Guzik M
and Guzik TJ: NADPH oxidases in vascular pathology. Antioxid Redox
Signal. 20:2794–2814. 2014. View Article : Google Scholar :
|
|
37
|
Garrido-Urbani S, Jemelin S, Deffert C,
Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet
X, Michalik L, et al: Targeting vascular NADPH oxidase 1 blocks
tumor angiogenesis through a PPARα mediated mechanism. PLoS One.
6:e146652011. View Article : Google Scholar
|
|
38
|
Ikeda S, Yamaoka-Tojo M, Hilenski L,
Patrushev NA, Anwar GM, Quinn MT and Ushio-Fukai M: IQGAP1
regulates reactive oxygen species-dependent endothelial cell
migration through interacting with Nox2. Arterioscler Thromb Vasc
Biol. 25:2295–2300. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Coso S, Harrison I, Harrison CB, Vinh A,
Sobey CG, Drummond GR, Williams ED and Selemidis S: NADPH oxidases
as regulators of tumor angiogenesis: Current and emerging concepts.
Antioxid Redox Signal. 16:1229–1247. 2012. View Article : Google Scholar : PubMed/NCBI
|
